Research and development
Atrys has launched diverse R&D projects in collaboration with leading academic and health centers.
In general, our projects focus on the integrated analysis of functional and molecular properties in different human tumor types to define a specific phenotype for each patient, altoghether with the development of models and tools for predicting therapeutic response in oncology that can generate marketable predictive test.
Atrys has been recognized as an innovative SME (Pyme Innovadora) by the Ministry of Economy and Competitiveness. This seal, created for small and medium-sized enterprises (SMEs), officially recognizes the effort of our company to research and innovate in the medical sector.